期刊文献+

^(99)锝-亚甲基双膦酸盐治疗乳腺癌术后化疗致骨质疏松症 被引量:3

Effect of ^(99)TC-MDP on Osteoporosis Caused by Postoperative Chemotherapy in Patients with Breast Cancer
下载PDF
导出
摘要 目的:探讨乳腺癌术后化疗对骨质密度变化的影响及(99)~锝-亚甲基双膦酸盐的治疗作用。方法:观察58例乳腺癌术后化疗患者化疗期间骨质密度、血钙素(BGP)、碱性磷酸酶(AKP)、24h尿钙水平变化。化疗结束后,将其中23例骨质疏松症患者分为对照组和观察组,对照组给予碳酸钙D3,观察组在对照组基础上加用(99)~锝-亚甲基双膦酸盐,治疗1年后比较两组患者骨质密度、BGP、AKP、24h尿钙水平变化。结果:化疗患者腰椎骨密度、股骨骨密度较化疗前显著降低,BGP、AKP、24 h尿钙则较前显著升高(P<0.05)。乳腺癌术后化疗3个疗程后骨质疏松症发生率为22.4%,化疗6个疗程后骨质疏松症发生率为39.7%。观察组患者腰椎骨密度、股骨骨密度较治疗前显著升高,BGP、AKP、24 h尿钙则显著降低;且两组比较,差异有统计学意义(P<0.05)。结论:乳腺癌术后化疗可导致骨质密度降低,使用(99)~锝-亚甲基双膦酸盐治疗乳腺癌术后化疗所致骨质疏松症安全有效。 Objective: To evaluate the effect of postoperative chemotherapy on bone density change in the patients with breast cancer and the therapeutic effect of 99 TC-MDP.Methods: Totally 58 breast cancer patients with postoperative chemotherapy were se-lected, and the changes of bone density , blood calcium element (BGP), alkaline phosphatase (ALP) and 24 h urinary calcium levels were observed .After the chemotherapy , the osteoporosis patients were divided into the control group and the observation group , and the control group was given calcium carbonate D 3, while the observation group was given calcium carbonate D 3 combined with 99 TC-MDP. The bone density , BGP, ALP and 24 h urinary calcium levels were compared between the two groups .Results:After the chemothera-py, the bone mineral density of lumbar vertebra and thighbone was decreased significantly , BGP, ALP and 24 h urine Ca were in-creased significantly, and compared with those before the treatment , the differences were statistically significant (P〈0.05).After the 3-course postoperative chemotherapy , the incidence of osteoporosis was 22.4%(13/58), and after the six-course chemotherapy, the incidence of osteoporosis was 39.7%(23/58).The bone mineral density of lumbar vertebra and thighbone in the observation group was increased significantly , BGP, ALP and 24 h urine Ca were decreased significantly , and compared with those in the control group , the differences were statistically significant (P〈0.05).Conclusion: Postoperative chemotherapy for breast cancer can lead to reduced bone density , and 99 TC-MDP in the treatment of osteoporosis induced by breast cancer postoperative chemotherapy is safe and effective .
出处 《中国药师》 CAS 2016年第7期1328-1330,共3页 China Pharmacist
基金 丽水市科技局科研基金资助项目(编号:2010JYZB23)
关键词 乳腺癌 骨质疏松症 (99)锝-亚甲基双膦酸盐 化疗 骨密度 Breast cancer Osteoporosis 99 TC-MDP Chemotherapy Bone mineral density
  • 相关文献

参考文献14

  • 1Stephens PJ, Tarpey PS, Davies H, et al. The landscape of cancer genes and mutational processes in breast cancer[ J ]. Nature, 2012, 486(7403 ) : 400-404. 被引量:1
  • 2Baselga J, Campone M, Piccart M, et al. Everolimus in postmenopa- usal hormone-receptor-positive advanced breast cancer[J]. New Eng- land Journal of Medicine, 2012, 366(6) : 520-529. 被引量:1
  • 3Lai K, Xu L, Jin C, et al. Technetium-99 conjugated with methylene diphosphonate (99Tc-MDP) inhibits experimental choroidal neovas- cularlzation in vivo and VEGF-induced cell migration and tube forma- tion in vitro [ J ]. Investigative ophthalmology & visual science, 2011, 52(8) : 5702-5712. 被引量:1
  • 4Newcomb PA, Trentham-Dietz A, Hampton JM. Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk[j], British journal of cancer, 2010, 102(5) : 799-802. 被引量:1
  • 5Helfrich MH, Evans DE, Grabowski PS, et al. Expression of nitric oxide synthase isoformas in bone cell cultures[J]. Bone Miner Res, 1997, 12(7) 51108-1115. 被引量:1
  • 6Powles TJ, Diem SJ, Fabian C J, et al. Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene [ J ], Breast cancer research and treatment, 2012, 134 ( 1 ) 299-306. 被引量:1
  • 7Vehmanen LK, Elomaa I, Blomqvist CP, et al. The effect of ovarian dysfunction on bone mineral density in breast cancer patients 10 years after adjuvant chemotherapy[J]. Acta Oncologica, 2014, 53 ( 1 ) : 75-79. 被引量:1
  • 8VanderWalde A, Hurria A. Aging and osteoporosis in breast and prostate cancer[ J ]. CA : a cancer journal for clinicians, 2011, 61 (3) : 139-156. 被引量:1
  • 9Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C, et al. Me- latonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation [ J ]. Expert opinion on investigational drugs, 2012, 21 (6) : 819-831. 被引量:1
  • 10Edwards BJ, Raisch DW, Shankaran V, et al. Cancer therapy asso- ciated bone loss : implications for hip fractures in mid-life women with breast cancer[J]. Clinical Cancer Research , 2011, 17(3) : 560-568. 被引量:1

同被引文献21

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部